Top Markets
#1 Siacoin Siacoin +35.47%
#2 Official Trump Official Trump +25.00%
#3 EXOD EXOD +22.08%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.57%
#5 MowCat MowCat +17.97%
#6 Melania Meme Melania Meme +17.87%
#7 Pump.fun Pump.fun +17.06%
#8 Unit Pump Unit Pump +17.06%
#9 The Bitcoin Bull The Bitcoin Bull +16.12%
#10 Siren Siren +15.73%
Coin of the day
Siacoin Siacoin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Rangering i aksjer #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Aksjekurs
$0.17616661
Sist synkronisert: 2026-08-21
Markedsverdi
$73.48M
Endring (1 dag)
0.18%
Endring (1 år)
-37.76%
Land
TW
Handel Mercury Biopharmaceutical Corporation (6932)

Kategori

Healthcare
P/S-forhold for Mercury Biopharmaceutical Corporation (6932)
P/S-forhold per 2026 TTM: 0
Ifølge Mercury Biopharmaceutical Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Mercury Biopharmaceutical Corporation fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 -
IN